BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6859379)

  • 21. Giant syncytia and virus-like particles in ovarian carcinoma cells isolated from ascites fluid.
    Rakowicz-Szulczynska EM; McIntosh DG; Smith ML
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):115-26. PubMed ID: 9874674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancer.
    Angelopoulou K; Diamandis EP
    Eur J Cancer; 1997 Jan; 33(1):115-21. PubMed ID: 9071910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of antigen-specific immunoglobulin content in ascitic fluids and antisera.
    Mariani M; Nucci D; Bracci L; Neri P; Antoni G
    J Immunol Methods; 1986 Sep; 92(2):189-93. PubMed ID: 2428882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunochemical study of antigens in the ascitic fluid of patients with ovarian cancer].
    Sergeeva NS; Vasil'ev MIu; Avdeev GI
    Eksp Onkol; 1986; 8(4):37-40. PubMed ID: 3757883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fc receptor-like structures on in vitro-cultured human ovarian tumor cells.
    Colnaghi MI; Regazzoni M; Boiocchi M; Galante E; Di Re F
    Tumori; 1978; 64(6):587-96. PubMed ID: 369078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Native membrane immunoglobulins and immunoglobulins bound to B lymphocyte membranes].
    Jarczok K; Hołowiecki J
    Pol Arch Med Wewn; 1984 Apr; 71(4):257-62. PubMed ID: 6333021
    [No Abstract]   [Full Text] [Related]  

  • 27. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
    Harłozińska A; Bar JK; Jothy S; Sedlaczek P; Slesak B; Richter R
    Tumour Biol; 1993; 14(1):1-8. PubMed ID: 7684152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Circulating immune complex of ovarian epithelial carcinoma and its clinical use].
    Cui H; Qian HN
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jul; 22(4):223-5, 253-4. PubMed ID: 3665670
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunosuppressive factors in ascites fluids from ovarian cancer patients.
    Fumita Y; Tanaka F; Saji F; Nakamuro K
    Am J Reprod Immunol (1980); 1984 Dec; 6(4):175-8. PubMed ID: 6528882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunological studies of ascitic fluid in patients with cirrhosis of the liver and hepatitis B surface antigen.
    Nakhla NB; Al-Saaty NY; Yaseen SA; Al-Talib AM; Shariff AY; Al-Hasso AR; Taka MT
    J Infect; 1983 Sep; 7(2):139-43. PubMed ID: 6644082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Extraction of immune ascitic fluids against group A Coxsackie viruses from white rats].
    Mikhaĭlovskaia TA; Linevich ZK; Konovalova OM
    Vopr Virusol; 1973; 18(5):609-11. PubMed ID: 4789251
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of the mechanism of tumor marker CA125 in serum].
    Kiyozuka Y; Noda T; Adachi S; Adachi S; Akada S; Ichijo M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1951-8. PubMed ID: 2592818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian tumor antigens: preliminary histological investigation.
    Daunter B; Jaa-Kwee D; Miklosi S; Wright G
    Gynecol Oncol; 1986 Mar; 23(3):364-70. PubMed ID: 3514391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal administration of interferon-gamma to carcinoma patients enhances expression of tumor-associated glycoprotein-72 and carcinoembryonic antigen on malignant ascites cells.
    Greiner JW; Guadagni F; Goldstein D; Smalley RV; Borden EC; Simpson JF; Molinolo A; Schlom J
    J Clin Oncol; 1992 May; 10(5):735-46. PubMed ID: 1569446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of antibodies recovered from immune complexes of ovarian cancer patients.
    Lutz PM; Dawson JR
    Cancer Immunol Immunother; 1984; 17(3):180-9. PubMed ID: 6383602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian cancer: immunologic diagnosis and therapy.
    Barber HR; Dorsett B
    Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
    [No Abstract]   [Full Text] [Related]  

  • 38. An ovarian cancer-associated antigen that crossreacts with a pregnancy-associated protein.
    Nakai M; Ohsawa Y; Nagata E; Arai M
    Eur J Obstet Gynecol Reprod Biol; 1987 Jan; 24(1):39-48. PubMed ID: 2434369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement and immunoglobulin levels in serum and ascitic fluid of patients with spontaneous bacterial peritonitis, malignant ascites, and tuberculous peritonitis.
    Yildirim B; Sezgin N; Sari R; Sevinc A; Hilmioglu F
    South Med J; 2002 Oct; 95(10):1158-62. PubMed ID: 12425501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.